查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1178084

脂质製剂的全球市场:脂质来源，各用途，各流通管道，各地区，产业规模，占有率，趋势，竞争，机会，预测(2017年～2027年)

Lipid Based Formulations Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027 Segmented By Source of Lipids, By Application, By Distribution Channel, By Region
出版日期: | 出版商: TechSci Research | 英文 113 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球脂质製剂的市场规模在预测期间(2023年～2027年)中预计将以惊人的年复合成长率成长。

对尖端医疗的需求剧增和口服给药药的需求增加，慢性疾病·感染疾病·传染病的增加，促进了市场的成长。

本报告提供全球脂质製剂市场相关调查分析，提供产品概要，市场展望，竞争情形等系统性资讯。

目录

第1章 产品概要

第2章 调查手法

第3章 全球脂质製剂市场上COVID-19影响

第4章 摘要整理

第5章 VOC (客户的迴响)

  • 偏好:脂质来源
  • 影响脂质製剂需求的因素
  • 采用基于脂质的製剂的障碍
  • 品牌知名度

第6章 临床试验

  • 进行中的临床试验
  • 完成的临床试验
  • 中断的临床试验
  • 临床试验分析

第7章 专利分析

  • 取得专利的(2017年～2021年)
  • 专利申请

第8章 市售的脂质製剂的清单

第9章 全球脂质製剂市场展望

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 脂质来源(天然化学合成)
    • 各用途(真菌性疾病，肿瘤学，基因治疗，抗病毒疫苗，其他)
    • 各流通管道(零售药局，医院药局，线上药局)
    • 各企业(2021年)
    • 各地区
  • 产品市场地图

第10章 北美的脂质製剂市场展望

第11章 欧洲的脂质製剂市场展望

第12章 亚太地区的脂质製剂市场展望

第13章 南美的脂质製剂市场展望

第14章 中东及非洲的脂质製剂市场展望

第15章 市场动态

  • 促进因素
  • 课题

第16章 市场趋势与开发

第17章 竞争情形

  • Novartis AG
  • AbbVie, Inc.
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Alnylam Pharmaceuticals Inc.

第18章 策略性建议

简介目录
Product Code: 8209

Global lipid based formulations market is anticipated to grow with an impressive CAGR in the forecast period, 2023-2027, on account of growing pharmaceutical industry. Rapidly surging demands for the advanced medicine and growing demand for oral administrated medicine is driving the growth of the global lipid formulations market in the upcoming five years.

Lipid based formulations are bio-chemical compounds that are artificially synthesized to facilitate the drug administration, while ensuring safety of the drug along with bio-solubility of it for the digestion and faster action of the main drug component inside the formulation. Lipid based formulations aid the primary mechanism of action for the drug that leads to bioavailability. In simpler terms, highly water soluble drugs if gets dissolved in the starting of gut, may not reach the target site, or target organ and thus its efficiency decreases. To alter this effect, a lipid based formulation is utilized. Lipids form a hydrophobic bonds around the drug and avoid dissolution partially or completely until it reaches the target site. With digestion of the lipid bonds by the process of triglyceride digestion, the drug gets delivered in the later parts of gastrointestinal tract.

Pharmaceutical Advancements Drive Market Growth

Consistent research and development of the drugs such that they have higher bio-availability, higher effect on the target site, to improve facilitation of the drug to create its effect at the target site, is driving the growth of the global lipid based formulations market in the upcoming five years. A major concern among the drug delivery system is that, for the oral administration of the drug, it has tendency to get dissolved or digested before reaching the target site. In such cases, the drug if get dissolved would leave the gastrointestinal tract without being absorbed in the blood. To avoid this untimely dissolution, lipid based formulations are utilized to enhance the drug durability and absorption thus substantially increasing its affinity as a treatment for a particular diseases.

Growing Investments In Healthcare Industry Supports Market

Governments from major economies are actively investing in their respective healthcare sectors to enhance the services and products such that best possible patient care can be provided. Increasing instances of chronic, infectious, and communicable diseases, is further anticipated to drive the growth of the global lipid based formulations market in the upcoming five years. Consistent research and technological advancement for the pharmaceutical product development and advancement of the drug delivery systems, is also anticipated to substantiate the growth of the global lipid based formulations market in the future five years.

Market Segmentation

The global lipid based formulations market segmentation is based on source of lipids, application, distribution channel, regional distribution, and competitive landscape. Based on source of lipids, the market is differentiated between natural and chemically synthesized sources. Application based segments of the market is distinguished among fungal diseases, oncology, gene therapy, antiviral vaccines, and others. Based on distribution channel, the market is fragmented into retail pharmacies, hospital pharmacies, and online pharmacies. The market analysis also studies the regional segmentation, divided among Asia-Pacific region, North American region, European region, South American region, and Middle East & African region.

Company Profile

Novartis AG, AbbVie, Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Alnylam Pharmaceuticals Inc., are enlisted in a partial list of major market players of the global lipid based formulations market.

Report Scope:

In this report, global lipid based formulations market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Lipid Based Formulations Market, By Source of Lipids:

Natural

Chemically Synthesized

  • Lipid Based Formulations Market, By Application:

Fungal Diseases

Oncology

Gene Therapy

Antiviral Vaccines

Others

  • Lipid Based Formulations Market, By Distribution Channel:

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

  • Lipid Based Formulations Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global lipid based formulations market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Lipid Based Formulations Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Preference, By Source of Lipids
  • 5.2. Factors Contributing to Demand for Lipid Based Formulations
  • 5.3. Barriers to Adoption of Lipid Based Formulations
  • 5.4. Brand Awareness

6. Clinical Trials

  • 6.1. Ongoing Clinical Trials
  • 6.2. Completed Clinical Trials
  • 6.3. Terminated Clinical Trials
  • 6.4. Clinical Trial Analysis

7. Patent Analysis

  • 7.1. Patent Granted (2017-2021)
  • 7.2. Patent Applications Filed

8. List of Commercially Available Lipid Based Formulations

9. Global Lipid Based Formulations Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Source of Lipids (Natural v/s Chemically Synthesized)
    • 9.2.2. By Application (Fungal Diseases, Oncology, Gene Therapy, Antiviral Vaccines, Others)
    • 9.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)
    • 9.2.4. By Company (2021)
    • 9.2.5. By Region
  • 9.3. Product Market Map

10. North America Lipid Based Formulations Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Source of Lipids
    • 10.2.2. By Application
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. North America: Country Analysis
    • 10.3.1. United States Lipid Based Formulations Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Source of Lipids
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Mexico Lipid Based Formulations Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Source of Lipids
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Canada Lipid Based Formulations Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Source of Lipids
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Distribution Channel

11. Europe Lipid Based Formulations Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Source of Lipids
    • 11.2.2. By Application
    • 11.2.3. By Distribution Channel
    • 11.2.4. By Country
  • 11.3. Europe: Country Analysis
    • 11.3.1. France Lipid Based Formulations Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Source of Lipids
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By Distribution Channel
    • 11.3.2. Germany Lipid Based Formulations Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Source of Lipids
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By Distribution Channel
    • 11.3.3. United Kingdom Lipid Based Formulations Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Source of Lipids
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By Distribution Channel
    • 11.3.4. Italy Lipid Based Formulations Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Source of Lipids
        • 11.3.4.2.2. By Application
        • 11.3.4.2.3. By Distribution Channel
    • 11.3.5. Spain Lipid Based Formulations Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Source of Lipids
        • 11.3.5.2.2. By Application
        • 11.3.5.2.3. By Distribution Channel

12. Asia-Pacific Lipid Based Formulations Market Outlook

  • 12.1. Market Size & Forecast
    • 12.1.1. By Value
  • 12.2. Market Share & Forecast
    • 12.2.1. By Source of Lipids
    • 12.2.2. By Application
    • 12.2.3. By Distribution Channel
    • 12.2.4. By Country
  • 12.3. Asia-Pacific: Country Analysis
    • 12.3.1. China Lipid Based Formulations Market Outlook
      • 12.3.1.1. Market Size & Forecast
        • 12.3.1.1.1. By Value
      • 12.3.1.2. Market Share & Forecast
        • 12.3.1.2.1. By Source of Lipids
        • 12.3.1.2.2. By Application
        • 12.3.1.2.3. By Distribution Channel
    • 12.3.2. India Lipid Based Formulations Market Outlook
      • 12.3.2.1. Market Size & Forecast
        • 12.3.2.1.1. By Value
      • 12.3.2.2. Market Share & Forecast
        • 12.3.2.2.1. By Source of Lipids
        • 12.3.2.2.2. By Application
        • 12.3.2.2.3. By Distribution Channel
    • 12.3.3. South Korea Lipid Based Formulations Market Outlook
      • 12.3.3.1. Market Size & Forecast
        • 12.3.3.1.1. By Value
      • 12.3.3.2. Market Share & Forecast
        • 12.3.3.2.1. By Source of Lipids
        • 12.3.3.2.2. By Application
        • 12.3.3.2.3. By Distribution Channel
    • 12.3.4. Japan Lipid Based Formulations Market Outlook
      • 12.3.4.1. Market Size & Forecast
        • 12.3.4.1.1. By Value
      • 12.3.4.2. Market Share & Forecast
        • 12.3.4.2.1. By Source of Lipids
        • 12.3.4.2.2. By Application
        • 12.3.4.2.3. By Distribution Channel
    • 12.3.5. Australia Lipid Based Formulations Market Outlook
      • 12.3.5.1. Market Size & Forecast
        • 12.3.5.1.1. By Value
      • 12.3.5.2. Market Share & Forecast
        • 12.3.5.2.1. By Source of Lipids
        • 12.3.5.2.2. By Application
        • 12.3.5.2.3. By Distribution Channel

13. South America Lipid Based Formulations Market Outlook

  • 13.1. Market Size & Forecast
    • 13.1.1. By Value
  • 13.2. Market Share & Forecast
    • 13.2.1. By Source of Lipids
    • 13.2.2. By Application
    • 13.2.3. By Distribution Channel
    • 13.2.4. By Country
  • 13.3. South America: Country Analysis
    • 13.3.1. Brazil Lipid Based Formulations Market Outlook
      • 13.3.1.1. Market Size & Forecast
        • 13.3.1.1.1. By Value
      • 13.3.1.2. Market Share & Forecast
        • 13.3.1.2.1. By Source of Lipids
        • 13.3.1.2.2. By Application
        • 13.3.1.2.3. By Distribution Channel
    • 13.3.2. Argentina Lipid Based Formulations Market Outlook
      • 13.3.2.1. Market Size & Forecast
        • 13.3.2.1.1. By Value
      • 13.3.2.2. Market Share & Forecast
        • 13.3.2.2.1. By Source of Lipids
        • 13.3.2.2.2. By Application
        • 13.3.2.2.3. By Distribution Channel
    • 13.3.3. Colombia Lipid Based Formulations Market Outlook
      • 13.3.3.1. Market Size & Forecast
        • 13.3.3.1.1. By Value
      • 13.3.3.2. Market Share & Forecast
        • 13.3.3.2.1. By Source of Lipids
        • 13.3.3.2.2. By Application
        • 13.3.3.2.3. By Distribution Channel

14. Middle East and Africa Lipid Based Formulations Market Outlook

  • 14.1. Market Size & Forecast
    • 14.1.1. By Value
  • 14.2. Market Share & Forecast
    • 14.2.1. By Source of Lipids
    • 14.2.2. By Application
    • 14.2.3. By Distribution Channel
    • 14.2.4. By Country
  • 14.3. MEA: Country Analysis
    • 14.3.1. South Africa Lipid Based Formulations Market Outlook
      • 14.3.1.1. Market Size & Forecast
        • 14.3.1.1.1. By Value
      • 14.3.1.2. Market Share & Forecast
        • 14.3.1.2.1. By Source of Lipids
        • 14.3.1.2.2. By Application
        • 14.3.1.2.3. By Distribution Channel
    • 14.3.2. Saudi Arabia Lipid Based Formulations Market Outlook
      • 14.3.2.1. Market Size & Forecast
        • 14.3.2.1.1. By Value
      • 14.3.2.2. Market Share & Forecast
        • 14.3.2.2.1. By Source of Lipids
        • 14.3.2.2.2. By Application
        • 14.3.2.2.3. By Distribution Channel
    • 14.3.3. UAE Lipid Based Formulations Market Outlook
      • 14.3.3.1. Market Size & Forecast
        • 14.3.3.1.1. By Value
      • 14.3.3.2. Market Share & Forecast
        • 14.3.3.2.1. By Source of Lipids
        • 14.3.3.2.2. By Application
        • 14.3.3.2.3. By Distribution Channel

15. Market Dynamics

  • 15.1. Drivers
  • 15.2. Challenges

16. Market Trends & Developments

17. Competitive Landscape

  • 17.1. Novartis AG
  • 17.2. AbbVie, Inc.
  • 17.3. F. Hoffmann-La Roche AG
  • 17.4. Johnson & Johnson
  • 17.5. Alnylam Pharmaceuticals Inc.

18. Strategic Recommendations